Posted on:
The key to long term weight loss and good health is not just a new, dynamic medication like Ozempic, but a much broader approach involving comprehensive support. This is a view held by leading endocrinologist and senior Kolling Institute researcher Professor Sarah Glastras, who is calling for a shift away from the perception that these
Category:
Posted on:
Leading pain specialist Professor Chris Vaughan has stepped down after a career spanning close to three decades. As a principal hospital scientist, Chris successfully juggled roles as a researcher, mentor and educator at Royal North Shore Hospital, the Kolling Institute and the University of Sydney. He has had a profound impact on the field of
Category:
Posted on:
As we live longer and there are more people living into old age, there is an increasing number of people developing dementia with more than 400,000 people currently living with the condition in Australia. Dementia is now the leading cause of death in Australia, and Alzheimer’s disease is the most common cause of dementia. Dementia
Category:
Posted on:
A new study by researchers at the Kolling Institute, in collaboration with the Microbiome Research Centre, has shown that multiple medication use impacts gut microbiome, and may influence the ageing process. Gizem Gemikonakli, a PhD student at the University of Sydney, said their findings followed a longitudinal, in vivo study. “Interestingly, mice that were given
Category:
Posted on:
A simple yet smart approach may hold the key to greatly improved health for those with life-changing spinal cord injuries. Researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research are launching a project to assess whether a specific breathing technique can improve many of the challenges faced by people with a spinal cord
Category:
Copyright © 2026 Kolling Institute
All rights reserved